N-Acetyl Carnosine

N-acetyl carnosine is a distinct compound from N-acetyl cysteine, despite both being abbreviated NAC in some contexts. N-Acetyl Carnosine (for eye use) is distinct from N-Acetyl Cysteine, despite sharing the NAC abbreviation. A large-scale human study involving 50,000 people demonstrated significant results for cataracts, glaucoma, and macular degeneration using NAC eye drops. A research paper documented cataract reversal after five months of using a 1% N-acetyl carnosine solution. Standard carnosine cannot penetrate the eye when applied topically because its molecular structure does not pass through the ocular surface. Attaching an N-acetyl group to carnosine allows the molecule to penetrate the eye directly when applied as drops. N-Acetyl Carnosine in drop form penetrates ocular tissue and reaches the lens directly, unlike regular carnosine. NAC carnosine eye drops for humans are difficult to find on mainstream retail platforms, with most listings formulated for animals. NAC eye drops are more effective for early-stage cataracts than for advanced ones.